Induction of Resistance to Antibody-mediated Cytotoxicity
نویسنده
چکیده
One of the main problems in the genetic analysis of a complex antigenic system is cross-reactivity of the antibodies defining individual antigens . Because of cross-reactivity it is often difficult, if not impossible, to determine the relationship between genetic structure on the one hand and molecular interrelationships among the antigens on the other hand . Although, theoretically, such a relationship can be elucidated by biochemical methods, the biochemical approach is complicted by the uncertainty whether the isolated products represent pieces of the membrane, molecules, or molecular fragments . Moreover, the biochemical methods are still too complicated to be used routinely in an ordinary serological analysis . Recently, two methods have become available that by-pass the difficulties indigenous to the biochemical analysis, and yet provide important information about the molecular interrelationship of individual antigens . Both methods are based on the assumption that independent molecules float freely in the cell membrane (1) and can be aggregated when combined with antibodies (2) . Of the two methods, namely, redistribution of antigens after exposure to fluorescent antibodies ("capping", cf. ref. 2) and acquisition of specific resistance to complement-dependent lysis after antigen redistribution ("lyso-strip", cf. ref. 3, 4), only the former has been utilized in the studies of the mouse H-2 complex (5) . In this report we describe an application of the lysostrip method to the H-2 system and provide evidence for independent movement in the lymphocyte membrane of H-2, Ia, and Ig antigens .
منابع مشابه
Ofatumumab Monoclonal Antibody Affinity Maturation Through in silico Modeling
Background: Ofatumumab, an anti-CD20 mAb, was approved in 2009 for the treatment of chronic lymphocytic leukemia. This mAb acts through immune-mediated mechanisms, in particular complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity by natural killer cells as well as antibody-dependent phagocytosis by macrophages. Apoptosis induction is another mechanism of this antibody...
متن کاملUnderstanding rituximab function and resistance: implications for tailored therapy.
The addition of anti-CD20 monoclonal antibody (rituximab) to chemotherapy has significantly improved survival in B-cell lymphoma. However, a substantial number of patients relapse after treatment with rituximab. Understanding of anti-CD20 antibody molecular function may facilitate the development of pharmacologic strategies to overcome resistance. Cell death have been demonstrated to be caused ...
متن کاملUnique toxicities and resistance mechanisms associated with monoclonal antibody therapy.
Anti-CD20 therapy has had a truly dramatic impact on treatment and outcome of patients with follicular lymphoma. Unfortunately, the majority of responses to single-agent rituximab are incomplete, and all patients with follicular lymphoma will experience disease progression at some point following rituximab therapy. Rituximab has multiple mechanisms of inducing in vivo cytotoxicity, including an...
متن کاملSplit anergized natural killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion
The mechanism of suppression of NK cytotoxicity in cancer patients is not clearly established. In this paper we provide evidence that anergized NK cells induce differentiation of healthy Dental Pulp Stem Cells (DPSCs) or transformed Oral Squamous Cancer Stem Cells (OSCSCs) resulting in cell growth inhibition, resistance to NK cell-mediated cytotoxicity and prevention of inflammatory mediators s...
متن کاملThe multidrug resistance phenotype confers immunological resistance
Multidrug resistance (MDR), which is due, in part, to the overexpression of P-glycoprotein, confers resistance to a variety of natural product chemotherapeutic agents such as daunorubicin, vincristine, and colchicine. RV+ cells are a P-glycoprotein overexpressing variant of the HL60 myeloid leukemia cell line. In addition to classic MDR, RV+ cells displayed relative resistance to complement-med...
متن کاملRituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
PURPOSE Rituximab [chimeric anti-CD20 monoclonal antibody], alone or combined with chemotherapy, is used in the treatment of non-Hodgkin's lymphoma (NHL). Rituximab binds to CD20 and inhibits intracellular survival/growth pathways leading to chemo/immunosensitization of tumor cells in vitro. The contribution of rituximab Fc-FcR interaction in signaling is not known. This study examined the role...
متن کامل